Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)

NCT00914095 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Gait Disorders, Neurologic
Dementia

Interventions

DRUG: methylphenidate
DRUG: placebo

Sponsor

University Hospital, Lille